Cargando…
Remarkable improvement in serum 25-hydroxyvitamin levels among hip fracture patients over a 12-year period: a prospective study in South-eastern Finland
SUMMARY: Hypovitaminosis D is a problem among hip fracture patients. In a 1-year cohort study comprising 245 hip fracture patients (mean age of females 81 years and males 78 years) from south-eastern Finland, the mean 25-hydroxyvitamin D [S-25(OH)D] concentration was 73(SD 31) nmol/L. Vitamin D supp...
Autores principales: | Nurmi-Lüthje, I., Tiihonen, R., Paattiniemi, E.-L., Naboulsi, H., Pigg, S., Sarkkinen, H., Kaukonen, J.-P., Toivanen, A., Salmio, K., Kataja, M., Lüthje, P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer London
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5854727/ https://www.ncbi.nlm.nih.gov/pubmed/29260288 http://dx.doi.org/10.1007/s00198-017-4344-1 |
Ejemplares similares
-
Relatively low and moderate pre-fracture serum 25-hydroxyvitamin D levels associated with the highest survival in elderly hip fracture patients in Finland: a minimum 3-year follow-up
por: Nurmi-Lüthje, I., et al.
Publicado: (2021) -
Correction to: Relatively low and moderate pre-fracture serum 25-hydroxyvitamin D levels associated with the highest survival in elderly hip fracture patients in Finland: a minimum 3-year follow-up
por: Nurmi-Lüthje, I., et al.
Publicado: (2021) -
Patient-specific factors affecting survival following hip fractures—a 14-year follow-up study in Finland
por: Tiihonen, Raine, et al.
Publicado: (2022) -
Evaluation of minimal fracture liaison service resource: costs and survival in secondary fracture prevention—a prospective one-year study in South-Finland
por: Lüthje, P., et al.
Publicado: (2021) -
Lessons learned from long-term side effects after zoledronic acid infusion following denosumab treatment: a case report and review of the literature
por: Nurmi-Lüthje, Ilona, et al.
Publicado: (2022)